A detailed history of Dixon Hubard Feinour & Brown Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Dixon Hubard Feinour & Brown Inc holds 3,783 shares of EW stock, worth $285,162. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,783
Previous 3,873 2.32%
Holding current value
$285,162
Previous $456,000 21.05%
% of portfolio
0.04%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022

SELL
$86.5 - $128.27 $7,785 - $11,544
-90 Reduced 2.32%
3,783 $360,000
Q1 2022

May 09, 2022

SELL
$101.96 - $128.34 $10,196 - $12,834
-100 Reduced 2.52%
3,873 $456,000
Q4 2021

Jan 10, 2022

BUY
$106.37 - $130.68 $113,496 - $139,435
1,067 Added 36.72%
3,973 $515,000
Q3 2021

Oct 19, 2021

BUY
$102.91 - $122.75 $1,543 - $1,841
15 Added 0.52%
2,906 $328,000
Q2 2021

Aug 23, 2021

SELL
$83.84 - $104.76 $13,414 - $16,761
-160 Reduced 5.24%
2,891 $299,000
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $240,052 - $276,634
3,051 New
3,051 $255,000
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $8.5 Million - $11.1 Million
-126,489 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$57.54 - $76.95 $4.73 Million - $6.33 Million
82,262 Added 186.0%
126,489 $9.8 Million
Q1 2020

May 15, 2020

SELL
$52.41 - $81.0 $108,488 - $167,670
-2,070 Reduced 4.47%
44,227 $8.34 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $13,623 - $15,597
190 Added 0.41%
46,297 $10.8 Million
Q3 2019

Nov 13, 2019

BUY
$61.55 - $75.43 $14,772 - $18,103
240 Added 0.52%
46,107 $10.1 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $12,262 - $14,170
220 Added 0.48%
45,867 $8.47 Million
Q1 2019

May 17, 2019

SELL
$47.89 - $64.05 $41,424 - $55,403
-865 Reduced 1.86%
45,647 $8.73 Million
Q4 2018

Feb 13, 2019

BUY
$46.41 - $56.94 $2.16 Million - $2.65 Million
46,512 New
46,512 $7.12 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.6B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Dixon Hubard Feinour & Brown Inc Portfolio

Follow Dixon Hubard Feinour & Brown Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dixon Hubard Feinour & Brown Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dixon Hubard Feinour & Brown Inc with notifications on news.